X-152869048-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_015922.3(NSDHL):c.1054C>T(p.Leu352Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00576 in 1,210,785 control chromosomes in the GnomAD database, including 23 homozygotes. There are 2,137 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0045 ( 1 hom., 153 hem., cov: 23)
Exomes 𝑓: 0.0059 ( 22 hom. 1984 hem. )
Consequence
NSDHL
NM_015922.3 synonymous
NM_015922.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.34
Genes affected
NSDHL (HGNC:13398): (NAD(P) dependent steroid dehydrogenase-like) The protein encoded by this gene is localized in the endoplasmic reticulum and is involved in cholesterol biosynthesis. Mutations in this gene are associated with CHILD syndrome, which is a X-linked dominant disorder of lipid metabolism with disturbed cholesterol biosynthesis, and typically lethal in males. Alternatively spliced transcript variants with differing 5' UTR have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BP6
Variant X-152869048-C-T is Benign according to our data. Variant chrX-152869048-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 159448.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-152869048-C-T is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=1.34 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00454 (512/112688) while in subpopulation NFE AF= 0.0071 (378/53264). AF 95% confidence interval is 0.00651. There are 1 homozygotes in gnomad4. There are 153 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 153 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NSDHL | NM_015922.3 | c.1054C>T | p.Leu352Leu | synonymous_variant | 8/8 | ENST00000370274.8 | NP_057006.1 | |
NSDHL | NM_001129765.2 | c.1054C>T | p.Leu352Leu | synonymous_variant | 9/9 | NP_001123237.1 | ||
NSDHL | XM_017029564.2 | c.1102C>T | p.Leu368Leu | synonymous_variant | 8/8 | XP_016885053.1 | ||
NSDHL | XM_011531178.3 | c.1054C>T | p.Leu352Leu | synonymous_variant | 10/10 | XP_011529480.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NSDHL | ENST00000370274.8 | c.1054C>T | p.Leu352Leu | synonymous_variant | 8/8 | 1 | NM_015922.3 | ENSP00000359297.3 | ||
NSDHL | ENST00000440023.5 | c.1054C>T | p.Leu352Leu | synonymous_variant | 9/9 | 5 | ENSP00000391854.1 |
Frequencies
GnomAD3 genomes AF: 0.00456 AC: 514AN: 112637Hom.: 1 Cov.: 23 AF XY: 0.00440 AC XY: 153AN XY: 34787
GnomAD3 genomes
AF:
AC:
514
AN:
112637
Hom.:
Cov.:
23
AF XY:
AC XY:
153
AN XY:
34787
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00477 AC: 874AN: 183245Hom.: 3 AF XY: 0.00447 AC XY: 303AN XY: 67725
GnomAD3 exomes
AF:
AC:
874
AN:
183245
Hom.:
AF XY:
AC XY:
303
AN XY:
67725
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00589 AC: 6468AN: 1098097Hom.: 22 Cov.: 31 AF XY: 0.00546 AC XY: 1984AN XY: 363453
GnomAD4 exome
AF:
AC:
6468
AN:
1098097
Hom.:
Cov.:
31
AF XY:
AC XY:
1984
AN XY:
363453
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00454 AC: 512AN: 112688Hom.: 1 Cov.: 23 AF XY: 0.00439 AC XY: 153AN XY: 34848
GnomAD4 genome
AF:
AC:
512
AN:
112688
Hom.:
Cov.:
23
AF XY:
AC XY:
153
AN XY:
34848
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:5
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 11, 2019 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Dec 11, 2013 | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Sep 08, 2015 | - - |
Child syndrome;C3151781:CK syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jul 19, 2021 | - - |
Connective tissue disorder Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Sep 01, 2019 | - - |
CK syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | May 18, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at